Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

诺迪康 - NMPA Drug Approval Details

Approvals/NMPA/诺迪康

Approved

中药

诺迪康

西藏诺迪康药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Apr 2, 2020
Approval ID: 7LeaeIgbfuM
Company: 西藏诺迪康药业股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeIgbfuM
Approval Number: 国药准字Z20020047
Generic Name: 十味蒂达胶囊
Brand Name: 诺迪康
Drug Type: 中药
Dosage Form: 胶囊剂
Strength: 每粒装0.45g
Reg Date: 2020-04-02
Company Name: 西藏诺迪康药业股份有限公司
Company Address: 西藏自治区拉萨经济技术开发区A区广州路3号
Production Company Name: 西藏诺迪康药业股份有限公司;四川诺迪康威光制药有限公司
Production Company Address: 西藏拉萨市北京中路93号；四川省广汉市向阳镇
Company Detail Path: /organization/tibet-rhodiola-pharmaceutical-holding-co

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 2, 2020

Approval ID

7LeaeIgbfuM

Type

中药

Back to NMPA Approvals